5
Participants
Start Date
September 30, 2012
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Weight loss group (Full meal replacement products)
In the intervention arm of this non randomized, open label study to assess the effects of weight loss on insulin sensitivity and leptin tolerance subjects will use full meal replacement products (1280-1320kcal/day). Subjects will be on the full meal replacement products only, for the first 12 weeks, between 13 to 19 weeks they will be transitioned to regular food, from 19 weeks and going forward they will be on chronic maintenance phase
Beth Israel Deaconess Medical Center, Boston
Beth Israel Deaconess Medical Center
OTHER